Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03320148
Other study ID # 6021536
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 20, 2017
Est. completion date January 15, 2019

Study information

Verified date March 2019
Source Queen's University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot cluster randomized controlled trial to determine the feasibility of a cluster randomized trial to evaluate the individual and health system impact of implementing a new physiotherapist-led primary care model for back pain in Canada.


Description:

This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with back pain. The primary purpose of this pilot study is to determine the feasibility including recruitment and retention of primary care teams (sites) and patient participants, carrying out the assessment procedures, and implementing the physiotherapist-led primary care intervention including training the physiotherapist to adopt this role.


Recruitment information / eligibility

Status Completed
Enrollment 100
Est. completion date January 15, 2019
Est. primary completion date January 15, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults (18 years and over) with back pain of any duration

- Seeking primary care for back pain at a participating site

- Primary care visit may be a first or repeat visit

Exclusion Criteria:

- Patients who do not consent to participation

- Patients who report being unable to understand, read, and write English

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Physiotherapist-led primary care model for back pain
Assessment and screening: taking a history; screening for red flags, comorbidities, and risk factors of ongoing pain and disability; physical examination Brief individualized intervention at the first visit: effective communication, cognitive reassurance, a few exercises, and advice/strategies to stay active. Health services navigation: PT assistance with navigating healthcare services based on the assessment findings. First, red-flags requiring emergency or urgent referrals. Next, comorbid conditions that would benefit from care from other healthcare providers. Finally, referral to PT (if appropriate). Providing additional physiotherapy care to people with an unmet need: Additional physiotherapy care will be provided to patients who have an identified need for physiotherapy but no physiotherapy coverage through private or government health insurance plans.
Other:
Usual care
The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.

Locations

Country Name City State
Canada Queen's University Kingston Ontario

Sponsors (2)

Lead Sponsor Collaborator
Queen's University Canadian Institutes of Health Research (CIHR)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recruitment of primary care teams Ability to recruit four primary care teams (Family Health Teams or Community Health Centres) to paricipate Baseline
Primary Recruitment of patient participants Recruitment rate (participants/week) or total number of participants recruited in 14 weeks Baseline to 14 weeks
Primary Assessment completion Percentage of all assessment items completed by participants completing each assessment Baseline, 6-week 12-week, 6,9,12 month follow-up. The primary time point for this assessment is 12-week follow-up.
Primary Retention of patient participants Attrition rate Retention of participants at 6-week, 12-week, 6, 9, and 12-month follow-up assessments. The primary timeline for this outcome is 12-month follow-up.
Primary Physiotherapist confidence in carrying out the interventions The PT will rate his/her confidence in each component of the intervention after the training on a scale from 0-10 with higher scores indicating greater confidence in carrying out that component of the intervention. Baseline
Primary Treatment fidelity Treatment fidelity will be measured by consistency with the intervention described in the protocol measured through an intervention checklist completed by the physiotherapist and an audit of the EMR notes. 6-week follow-up
Secondary Self-reported disability measured using the Roland Morris Disability Questionnaire (0 to 24 with higher scores indicating greater disability) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Self-reported pain intensity measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity (measured at rest, during walking, and during a lifting task) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Health Related Quality of Life measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Global rating of change measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning related to back pain and positive scores indicating an improvement of physical functioning related to back pain) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Satisfaction with health care measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Catastrophic Thinking measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Depressive symptoms measured using the 9-item Patient Health Questionnaire (PHQ-9) (0 to 27 with greater scores indicating increased depressive symptoms) Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Adverse events measured using an adverse events questionnaire that asks 1) if the patient has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced. Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Health care accessibility Percentage of patients receiving care within 48 hours. Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Health care accessibility Percentage of patients who score medium or high risk on the STarT Back tool who receive physiotherapy care. Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Health care utilization All health care visits (aggregated and dis-aggregated) including: primary care visits, emergency department visits, hospitalizations, surgeries, consultations with other health care providers, diagnostic imaging, medications, and other care received by the patient Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Costs (piloted for a cost utility analysis in a future trial) Includes all health care costs plus societal costs using a human capital approach for loss of productivity Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Medications prescribed Measured as a process outcome Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary Diagnostic imaging ordered Measured as a process outcome Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary referrals to other health care providers made Measured as a process outcome Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Secondary notes made by primary care provider to employers or insurers Measured as a process outcome Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
See also
  Status Clinical Trial Phase
Completed NCT05982483 - Erector Spinae Plane Block vs. Usual Care for ED Patients With Mechanical Back Pain N/A
Completed NCT04744246 - Muscle Activity During Load Carriage in ROTC Cadets N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Active, not recruiting NCT03680846 - Comparison of HF10 Therapy Combined With CMM to CMM Alone in the Treatment of Non-Surgical Refractory Back Pain N/A
Completed NCT05597189 - Clinical Study for Palliative/Preventive Treatment of Chronic Back Pain N/A
Completed NCT05342181 - Static and Dynamic Core Stability Exercises in Potpartum Back Pain N/A
Completed NCT02955342 - Back and Neck Pain in Adolescence
Not yet recruiting NCT02536274 - "Examination of the Impact of a Dynamic Flexion Orthosis (Dynaflex®Ottobock) or of a Back Bandage (Lumbo Sensa®Ottobock) on the Voluntary Activation of the Back Muscles in Patients With Specific Back Pain" N/A
Completed NCT02704845 - Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain N/A
Recruiting NCT02237105 - The Effect of Cognitive Behavioral Therapy on the Outcome of Spinal Surgery N/A
Enrolling by invitation NCT02485795 - Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management N/A
Terminated NCT02239627 - Epidural Clonidine Versus Corticosteroid for Low Back Pain N/A
Completed NCT02609009 - Back Pain and Spinal Manipulation in Adolescent Scoliosis N/A
Completed NCT02254694 - The Influence of High Heeled Shoes on the Sagittal Balance of the Spine and Whole Body N/A
Completed NCT00986180 - NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain Phase 3
Completed NCT00771758 - Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Phase 3
Terminated NCT00769626 - Standardizing Management of Patients With Low Back Pain in Primary Care and Physical Therapy Phase 3
Withdrawn NCT00231374 - Measure of Cerebrospinal Fluid (CSF) Pressure Variation With Patient Positioning N/A
Completed NCT00454064 - Cognitive-behavioural Treatment of Chronic Back Pain Phase 3
Completed NCT00103675 - Sensor Measurement of Acupuncture Needle Manipulation Phase 1